Anisha Patel

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Matthew Campbell

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Vincent K. Lam

Johns Hopkins University School of Medicine

UNITED STATES

View details

J. Jack Lee

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Cara Haymaker

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Rami Al-Rohil

Associate Professor

Duke University

UNITED STATES

View details

Don L. Gibbons

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

YASIR ELAMIN

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jacqulyne Robichaux

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anisha Patel

Research Interests

Explore related searches

Contact this professor

Articles (18)

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors

Cutaneous lupus erythematosus presenting as a nonhealing ulcer in an African American woman: A case report

Cutaneous toxicities secondary to STAT3 inhibition: A retrospective case series

Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin: Single-Center Case Series

A retrospective case series of eight patients with epidermal growth factor receptor inhibitor–induced cutaneous toxicities managed with dupilumab

Clinicopathologic correlation of dermatologic diseases in patients with darker pigmentation

Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1

Resolution of metastatic cutaneous Crohn's disease with upadacitinib monotherapy

Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer

Altmetric Analysis of Dermatology Manuscript Dissemination During the COVID-19 Era: Cross-Sectional Study

Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features

Immune checkpoint inhibitor-induced vitiligo in cancer patients: characterization and management

Poziotinib for Patients With HER2 Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial

Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy

Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy

Collaborators (8)

Matthew Campbell

Vincent K. Lam

J. Jack Lee

Cara Haymaker

Rami Al-Rohil

Don L. Gibbons

YASIR ELAMIN

Jacqulyne Robichaux

Make your next move.